相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic activity assessment by 18F-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization
Do Young Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Prognostic value of imaging-based parameters in patients with intermediate-stage hepatocellular carcinoma undergoing transarterial radioembolization
Ameya D. Puranik et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1. in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
Jae Seung Lee et al.
GUT AND LIVER (2020)
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia
Hanhee Jo et al.
SCIENTIFIC REPORTS (2020)
Predicting tumor recurrence using metabolic indices of 18F-FDG PET/CT prior to orthotopic liver transplantationfor hepatocellular carcinoma
Enci Ding et al.
ONCOLOGY LETTERS (2020)
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study
Anne-Laure Hermann et al.
RADIOLOGY (2020)
Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma
Paul Blanc-Durand et al.
ONCOTARGET (2018)
Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription
Chi Lai Ho et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analyses
Ahsun Riaz et al.
HEPATOLOGY (2018)
Anatomic versus Metabolic Tumor Response Assessment after Radioembolization Treatment
Jennifer M. J. Jongen et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and 18F-fluoro-2-deoxyglucose positron emission tomography
Woo Joong Rhee et al.
LIVER INTERNATIONAL (2017)
18F-FDG PET/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma
Mario Jreige et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection
Jeong Won Lee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma
Sang Hyun Hwang et al.
CLINICAL NUCLEAR MEDICINE (2017)
Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT
Sang Hyun Hwang et al.
CLINICAL NUCLEAR MEDICINE (2016)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT
Yong-il Kim et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
Yazan Abuodeh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis
Jeong Won Lee et al.
ANNALS OF NUCLEAR MEDICINE (2015)
PET/CT- Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on 99mTc-MAA Imaging and Correlation With Treatment Efficacy
Yoo Sung Song et al.
MEDICINE (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis
Annagiulia Gramenzi et al.
LIVER INTERNATIONAL (2015)
Prognostic value of pretreatment 18F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
In Young Jo et al.
RADIATION ONCOLOGY JOURNAL (2015)
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer
Jeong Won Lee et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Prognostic Importance of 18F-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT
Ozlem N. Kucuk et al.
CLINICAL NUCLEAR MEDICINE (2013)
18F-Fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma
Myeong Jun Song et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma
Zhihong Weng et al.
ONCOLOGY LETTERS (2013)
Prognostic value of metabolic tumor burden on F-18-FDG PET in nonsurgical patients with non-small cell lung cancer
Shengri Liao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
USEFULNESS OF POSITRON EMISSION TOMOGRAPHY WITH FLUORINE-18-FLUORODEOXYGLUCOSE IN PREDICTING TREATMENT RESPONSE IN UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH EXTERNAL BEAM RADIOTHERAPY
Jun Won Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Patients with non-[18F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation
Arno Kornberg et al.
LIVER TRANSPLANTATION (2012)
18F-fluorodeoxyglucose Uptake on Positron Emission Tomography as a Prognostic Predictor in Locally Advanced Hepatocellular Carcinoma
Beom Kyung Kim et al.
CANCER (2011)
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2011)
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
Hyun Hoon Chung et al.
GYNECOLOGIC ONCOLOGY (2011)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancer
Lourens Bester et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2011)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
